Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Oligonucleotide Synthesis Market Value Analysis: What Growth Is Expected Over The Forecast Period?
The oligonucleotide synthesis market experienced substantial expansion recently, projecting a rise from $11.92 billion in 2025 to $13.9 billion in 2026, fueled by a compound annual growth rate of 16.6%. This past growth was influenced by factors such as the significant expense of synthesis machinery, restricted access to bespoke oligonucleotides, reliance on manual production methods, a lack of widespread researcher awareness, and extended manufacturing schedules.
The oligonucleotide synthesis sector is poised for substantial expansion, projected to reach a market valuation of $26.08 billion by 2030, driven by a compound annual growth rate (CAGR) of 17.1%. This upward trajectory during the projected timeframe will be fueled by several key factors, including escalating demand stemming from therapeutic and diagnostic uses, a heightened uptake of automated synthesis technologies, significant progress in gene therapy investigations, increased financial commitment to biotechnology research, and a broader geographical reach for oligo-based studies and diagnostic tools. Within this forecast period, prominent developments are expected to center on breakthroughs in gene editing and tailored medical approaches, the incorporation of cloud-based systems for data administration, the utilization of artificial intelligence to refine sequence design and optimization, the streamlining of oligonucleotide synthesis through automation, and the deployment of IoT-enabled devices for equipment oversight and operational monitoring.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12176&type=smp
Oligonucleotide Synthesis Market Opportunity Drivers: What Is Creating New Revenue Potential?
The increasing incidence of long-term health conditions is anticipated to fuel the expansion of the oligonucleotide synthesis market. These chronic conditions, defined as ailments persisting for a year or more and necessitating ongoing medical care, have the potential for deterioration. Oligonucleotides exert influence on the genetic expression pathways associated with these chronic diseases through diverse methods, including targeting messenger RNA, precursor messenger RNA, or non-coding RNA to influence splicing, trigger degradation, or disrupt protein synthesis. Illustratively, projections from the World Health Organization, a global intergovernmental body headquartered in Switzerland, indicated in February 2024 that by 2050, an estimated 35 million new cancer diagnoses were foreseen, signifying a substantial 77% increase from the approximately 20 million cases estimated for 2022, thereby highlighting how the escalating rates of chronic and rare diseases are serving as a catalyst for the growth observed in the oligonucleotide synthesis sector.
Oligonucleotide Synthesis Market Segment Landscape: Which Areas Lead Market Development?
The oligonucleotide synthesis market covered in this report is segmented –
1) By Type: Custom Oligos, Predesigned Oligos
2) By Solution Type: Oligonucleotides, Reagents, Equipment, Services, Purification, Modification
3) By Application: Therapeutic Applications, Research Applications, Diagnostic Applications
Subsegments:
1) By Custom Oligos: Long Oligonucleotides, Short Oligonucleotides, Modified Oligonucleotides
2) By Predesigned Oligos: Gene-Specific Oligos, Probe Oligos, Primers For PCR And RT-PCR
Oligonucleotide Synthesis Market Innovation Trends Driving Future Development
Pioneering firms within the oligonucleotide synthesis sector are dedicating their efforts to creating novel DNA solutions. These advancements aim to boost the precision of sequences, streamline procedural steps, and facilitate sophisticated research endeavors. A notable development occurred in July 2024 when Ansa Biotechnologies, Inc., a prominent US entity known for its expertise in intricate DNA production, introduced two new offerings: Ansa Clonal DNA and Ansa DNA Fragments. The former delivers DNA that is clonal and precisely matches its intended sequence, extending up to 600 base pairs. This eliminates the requirement for assembly processes and furnishes exceptional accuracy, proving invaluable for ambitious synthetic biology endeavors by providing developers with error-free, immediately usable DNA sequences. Complementing this, Ansa DNA Fragments presents linear double-stranded DNA fragments, also capped at 600 base pairs, that have undergone sequence verification and are designed for a broad spectrum of research objectives. Through its inventive enzymatic synthesis methodology, Ansa consistently manufactures complex DNA structures, encompassing repetitive elements and challenging secondary formations, with a high degree of exactitude.
Oligonucleotide Synthesis Market Industry Leaders And Market Competition
Major companies operating in the oligonucleotide synthesis market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, GE HealthCare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Nitto Denko Avecia Inc., Alnylam Pharmaceuticals Inc., Maravai Life Sciences, LGC Limited, Ionis Pharmaceuticals Inc., GenScript Inc., Ajinomoto Bio-Pharma Services, Sarepta Therapeutics Inc., Integrated DNA Technologies Inc., Twist Bioscience Corporation, Eurogentec SA, Kaneka Eurogentec S.A., Biocomma Limited, Bio-Synthesis Inc., TriLink BioTechnologies Incorporated, Generi Biotech s.r.o., ATDBio Ltd., BioAutomation Corporation, Biolegio B.V., Dharmacon Research Inc.
Access The Complete Oligonucleotide Synthesis Market Report:
https://www.thebusinessresearchcompany.com/report/oligonucleotide-synthesis-global-market-report
Oligonucleotide Synthesis Market Regional Analysis And Leading Geography
North America was the largest region in the oligonucleotide synthesis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oligonucleotide synthesis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
